Literature DB >> 9412967

Fecal incontinence in scleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications.

B W Jaffin1, P Chang, H Spiera.   

Abstract

Fecal incontinence is an under-reported complication of scleroderma. Ten incontinent patients with scleroderma were evaluated through anorectal manometry and compared with 20 incontinent patients without scleroderma who were matched for age and sex as controls. The scleroderma patients had a higher voluntary external anal squeeze pressure, whereas the resting internal anal sphincter pressure was similar to that of the control group. The threshold for rectal sensation in the scleroderma group was significantly less than that in controls. Episodes of fecal incontinence, anal canal length, and maximal tolerable volume were not significantly different between the study groups. The rectoanal inhibitory response was abnormal in 80% of patients with systemic sclerosis but was normal in 70% of the controls. Stool consistency was significantly looser in the scleroderma patients. Treatment of fecal incontinence in scleroderma patients may be successful in many patients using a combination of dietary and pharmacologic manipulation because diarrhea is an important etiologic cofactor superimposed on reduced internal anal sphincter pressure.

Entities:  

Mesh:

Year:  1997        PMID: 9412967     DOI: 10.1097/00004836-199710000-00006

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

Review 2.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

3.  Anal physiology testing in fecal incontinence: is it of any value?

Authors:  Massarat Zutshi; Levilester Salcedo; Jeffrey Hammel; Tracy Hull
Journal:  Int J Colorectal Dis       Date:  2009-11-10       Impact factor: 2.571

4.  Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence.

Authors:  Gregory J Heyt; Mina K Oh; Nazanin Alemzadeh; Susie Rivera; Sergio A Jimenez; Satish Rattan; Sidney Cohen; Anthony J Dimarino
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

Review 5.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

6.  Prevalence of fecal incontinence in a cohort of systemic sclerosis patients within a regional referral network.

Authors:  A Garros; S Marjoux; C Khouatra; B Coppere; C Grange; A Hot; S Roman; H Damon; F Mion
Journal:  United European Gastroenterol J       Date:  2017-01-11       Impact factor: 4.623

7.  Anorectal motility and sensation abnormalities and its correlation with anorectal symptoms in patients with systemic sclerosis: a preliminary study.

Authors:  Hanaa S Sallam; Terry A McNearney; Jiande Z Chen
Journal:  ISRN Gastroenterol       Date:  2011-06-06

8.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Isabel M McFarlane; Manjeet S Bhamra; Alexandra Kreps; Sadat Iqbal; Firas Al-Ani; Carla Saladini-Aponte; Christon Grant; Soberjot Singh; Khalid Awwal; Kristaq Koci; Yair Saperstein; Fray M Arroyo-Mercado; Derek B Laskar; Purna Atluri
Journal:  Rheumatology (Sunnyvale)       Date:  2018-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.